DeA Capital Alternative Funds-backed Taste of Italy 2 completed the acquisition of a 55% stake in Avantea.

DeA Capital Alternative Funds-backed Taste of Italy 2, a private equity fund, completed the acquisition of a 55% stake in Avantea, an animal reproduction and biotechnology research laboratory. Financial terms were not disclosed. “We are strongly convinced that with the support of Taste of Italy we will accelerate Avantea’s growth path, both in the domestic and foreign markets, consolidating our positioning, maintaining the high quality of our services and intensifying the research and development activity that has always underpinned our ability to lead the technological development of the industry,” Giovanna Lazzari, Avantea Co-Founder.